Skip to main content

Advertisement

SpringerLink
Log in

Advances in prostate cancer imaging techniques and strategies

  • Focus on
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grönberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859-64. Mar 8.

    Article  PubMed  Google Scholar 

  2. Kumar RJ, Barqawi Al Baha, Crawford ED. Epidemiology of Prostate Cancer. Business Briefing: US Oncology Review 2004 http://www.touchoncologicaldisease.com/epidemiology-prostate-cancer-a2494-1.html.

  3. Oehr P, Bouchelouche K. Imaging of prostate cancer. Curr Opin Oncol. 2007;19(3):259-64. May.

    Article  PubMed  Google Scholar 

  4. Pallwein L, Mitterberger M, Pelzer A, Bartsch G, Strasser H, Pinggera GM, et al. Ultrasound of prostate cancer: recent advances. Eur Radiol. 2007 Oct 16 [Epub ahead of print]. DOI 10.1007/s00330-007-0779-7.

  5. Zalesky M, Urban M, Smerhovský Z, Zachoval R, Lukes M, Heracek J. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer. Int J Urol. 2008;15(1):68-75. Jan.

    Article  PubMed  Google Scholar 

  6. Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007;70(6):1136-40. Dec.

    Article  PubMed  Google Scholar 

  7. Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008;18(1):71-7. Jan.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008;246(1):177-84. Jan.

    Article  PubMed  Google Scholar 

  9. Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3 T using a phased-array coil: preliminary results. Invest Radiol. 2007;42(12):842-7. Dec.

    Article  PubMed  Google Scholar 

  10. Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology. 2008;246(1):168-76. Jan.

    Article  PubMed  Google Scholar 

  11. Bouchelouche K, Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol. 2008;179(1):34-45. Jan.

    Article  CAS  PubMed  Google Scholar 

  12. Takahashi N, Inoue T, Lee J, Yamaguchi T, Shizukuishi K. The roles of PET and PET/CT in the diagnosis and management of prostate cancer. Oncology. 2007;72(3-4):226-33.

    Article  PubMed  Google Scholar 

  13. Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi V, Cozzarini C, et al. [11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging. 2008 Jan 16; [Epub ahead of print]. DOI 10.1007/s00259-008-0716-2.

  14. Eschmann SM, Pfannenberg AC, Rieger A, Aschoff P, Müller M, Paulsen F, et al. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin. 2007;46(5):161-8.

    CAS  PubMed  Google Scholar 

  15. Vavere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-Acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008 Jan 16; [Epub ahead of print]. DOI 10.2967/jnumed.107.046672.

  16. Schiepers C, Hoh CK, Nuyts J, Seltzer M, Wu C, Huang SC, et al. 1-11C-Acetate kinetics of prostate cancer. J Nucl Med. 2008 Jan 16; [Epub ahead of print]. DOI 10.2967/jnumed.107.044453.

  17. Manikandan R, Qazi HA, Philip J, Mistry R, Lamb GH, Woolfenden KA, et al. Routine use of magnetic resonance imaging in the management of T(1c) carcinoma of the prostate: is it necessary. J Endourol. 2007;21(10):1171-4. Oct.

    Article  PubMed  Google Scholar 

  18. Shukla-Dave A, Hricak H, Scardino PT. Imaging low-risk prostate cancer. Curr Opin Urol. 2008;18(1):78-86. Jan.

    Article  PubMed  Google Scholar 

  19. Fuchsjäger M, Shukla-Dave A, Akin O, Barentsz J, Hricak H. Prostate cancer imaging. Acta Radiol. 2008;49(1):107-20. Feb.

    Article  PubMed  Google Scholar 

  20. Larson SM, Schöder H. Advances in positron emission tomography applications for urologic cancers. Curr Opin Urol. 2008;18(1):65-70. Jan.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

This commentary derives from a literature search of recently published articles and draws extensively on the texts of the articles referenced.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucignani, G. Advances in prostate cancer imaging techniques and strategies. Eur J Nucl Med Mol Imaging 35, 1019–1025 (2008). https://doi.org/10.1007/s00259-008-0784-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-008-0784-3

Keywords

Search

Navigation